Pages that link to "Q50042941"
Jump to navigation
Jump to search
The following pages link to The in vitro effects of niacin on platelet biomarkers in human volunteers. (Q50042941):
Displaying 9 items.
- Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin (Q30453962) (← links)
- Role of platelet function and platelet membrane glycoproteins in children with primary immune thrombocytopenia (Q33433995) (← links)
- Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation (Q34368772) (← links)
- Prolonged niacin treatment leads to increased adipose tissue PUFA synthesis and anti-inflammatory lipid and oxylipin plasma profile. (Q34565247) (← links)
- Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients (Q35400988) (← links)
- Pleiotropic effects of niacin: Current possibilities for its clinical use. (Q38810790) (← links)
- Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia (Q43557403) (← links)
- Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system. (Q47618059) (← links)
- Effects of nicotinic acid on endothelial cells and platelets (Q84244291) (← links)